These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 29386230

  • 1. Modifying impact of RET gene haplotypes on medullary thyroid carcinoma clinical course.
    Kaczmarek-Ryś M, Ziemnicka K, Pławski A, Budny B, Michalak M, Hryhorowicz S, Hoppe-Gołębiewska J, Boruń P, Gołąb M, Czetwertyńska M, Sromek M, Szalata M, Ruchała M, Słomski R.
    Endocr Relat Cancer; 2018 Apr; 25(4):421-436. PubMed ID: 29386230
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [Abstract] [Full Text] [Related]

  • 3. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.
    Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG.
    Fam Cancer; 2017 Apr; 16(2):283-289. PubMed ID: 27864651
    [Abstract] [Full Text] [Related]

  • 4. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ, Yüksel B, Tuna MM, Navdar Başaran M, Akkurt Kocaeli A, Ertörer ME, Aydın K, Güldiken S, Şimşek Y, Cihan Karaca Z, Yılmaz M, Aktürk M, Anaforoğlu İ, Kebapçı N, Duran C, Taşlıpınar A, Kulaksızoğlu M, Gürsoy A, Dağdelen S, Erdoğan MF.
    J Clin Res Pediatr Endocrinol; 2016 Mar 05; 8(1):13-20. PubMed ID: 26758973
    [Abstract] [Full Text] [Related]

  • 5. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T.
    Thyroid; 2016 Sep 05; 26(9):1225-38. PubMed ID: 27400880
    [Abstract] [Full Text] [Related]

  • 6. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.
    Thyroid; 2017 Dec 05; 27(12):1511-1522. PubMed ID: 28946813
    [Abstract] [Full Text] [Related]

  • 7. [Familial medullary thyroid carcinoma: case report and literature review.].
    Barletta Carrillo CF, Poterico Rojas JA, Barrionuevo Cornejo C, Casavilca Zambrano S, Pinedo Cárdenas A, Quispe Santibañez I, Castro Mujica MDC.
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec 12; 75(4):303-309. PubMed ID: 30734711
    [Abstract] [Full Text] [Related]

  • 8. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.
    Endocr Relat Cancer; 2010 Dec 12; 17(4):953-63. PubMed ID: 20801952
    [Abstract] [Full Text] [Related]

  • 9. Genotype-specific progression of hereditary medullary thyroid cancer.
    Machens A, Lorenz K, Weber F, Dralle H.
    Hum Mutat; 2018 Jun 12; 39(6):860-869. PubMed ID: 29656518
    [Abstract] [Full Text] [Related]

  • 10. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
    Barletta JA, Nosé V, Sadow PM.
    Endocr Pathol; 2021 Mar 12; 32(1):35-43. PubMed ID: 33492588
    [Abstract] [Full Text] [Related]

  • 11. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K, Raue F.
    Recent Results Cancer Res; 2015 Mar 12; 204():139-56. PubMed ID: 26494387
    [Abstract] [Full Text] [Related]

  • 12. Rare RET Variant p.D707E in a Chinese Pedigree with Hereditary Medullary Thyroid Carcinoma.
    Zhang L, Li X, Li Q, Ge S, Chen M, Huang S, Chen B, Li P, Teng B, Xu J, Zhao S, Qi F, Zhang Y.
    Pathobiology; 2017 Mar 12; 84(3):152-160. PubMed ID: 27798940
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma.
    Magalhães PK, de Castro M, Elias LL, Soares EG, Maciel LM.
    Thyroid; 2004 Oct 12; 14(10):848-52. PubMed ID: 15588382
    [Abstract] [Full Text] [Related]

  • 14. Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.
    Smith J, Read ML, Hoffman J, Brown R, Bradshaw B, Campbell C, Cole T, Navas JD, Eatock F, Gundara JS, Lian E, Mcmullan D, Morgan NV, Mulligan L, Morrison PJ, Robledo M, Simpson MA, Smith VE, Stewart S, Trembath RC, Sidhu S, Togneri FS, Wake NC, Wallis Y, Watkinson JC, Maher ER, McCabe CJ, Woodward ER.
    Hum Mol Genet; 2016 May 01; 25(9):1836-45. PubMed ID: 26945007
    [Abstract] [Full Text] [Related]

  • 15. Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan.
    Chang CF, Yang WS, Su YN, Wu IL, Chang TC.
    J Formos Med Assoc; 2009 May 01; 108(5):402-8. PubMed ID: 19443294
    [Abstract] [Full Text] [Related]

  • 16. The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.
    Dabir T, Hunter SJ, Russell CF, McCall D, Morrison PJ.
    Fam Cancer; 2006 May 01; 5(2):201-4. PubMed ID: 16736292
    [Abstract] [Full Text] [Related]

  • 17. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec 01; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 18. The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma.
    Qi XP, Zhang RX, Cao JL, Chen ZG, Jin HY, Yang RR.
    J Biosci; 2014 Jun 01; 39(3):505-12. PubMed ID: 24845513
    [Abstract] [Full Text] [Related]

  • 19. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.
    Auris Nasus Larynx; 2016 Oct 01; 43(5):551-5. PubMed ID: 26837867
    [Abstract] [Full Text] [Related]

  • 20. Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation.
    Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ.
    Thyroid; 2016 Dec 01; 26(12):1744-1751. PubMed ID: 27673361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.